Safety and Efficacy of Elobixibat, an Ileal Bile Acid Transporter Inhibitor, in Elderly Patients With Chronic Idiopathic Constipation According to Administration Time: Interim Analysis of Post-marketing Surveillance.

Nakajima, Atsushi; Fujimaki, Mio; Arai, Yuki; Emori, Kento

Nakajima, Atsushi; Fujimaki, Mio; Arai, Yuki; Emori, Kento.

Afiliação

Nakajima A; Department of Gastroenterology and Hepatology, Yokohama City University School of Medicine, Yokohama, Japan.
Fujimaki M; Medical Department, EA Pharma Co, Ltd, Tokyo, Japan.
Arai Y; Medical Department, EA Pharma Co, Ltd, Tokyo, Japan.
Emori K; Clinical Development Department, EA Pharma Co, Ltd, Tokyo, Japan.

J Neurogastroenterol Motil ; 28(3): 431-441, 2022 Jul 30.

Article em En | MEDLINE | ID: mdl-35799237

Palavras-chave

Bile acids; Constipation; Elobixibat; Product surveillance; postmarketing

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 3_ND Base de dados: MEDLINE Tipo de estudo: Screening_studies Idioma: En Revista: J Neurogastroenterol Motil Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google